[EN] 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINES AS MODULATORS OF GPR139<br/>[FR] 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINES UTILISÉES EN TANT QUE MODULATEURS DE GPR139
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2016081736A1
公开(公告)日:2016-05-26
The present invention provides a method for treating a disease, disorder or condition associated with GPR139 using compounds of formula (1), which are agonists of GPR139, certain compounds encompassed by formula (1), pharmaceutical compositions thereof, processes for making the compounds, and intermediates thereof.
Inhibitors of Hepatitis C virus NS3 serine protease
申请人:VERTEX PHARMACEUTICALS INCORPORATED
公开号:EP2314598A1
公开(公告)日:2011-04-27
The present invention relates to compounds, methods and pharmaceutical compositions for inhibiting proteases, particularly serine proteases, and more particularly HCV NS3 proteases. The compounds, and the compositions and_methods that utilize them, can be used, either alone or in combination to inhibit viruses, particularly HCV virus.